文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：OIT3通过介导铁死亡调节花生四烯酸代谢，作为肝细胞癌的一种新型生物标志物。

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis regulating the arachidonic acid metabolism.

作者信息

Wen Jie, Aili Abudureyimujiang, Yan Yao Xue, Lai YuLin, Niu Shaoqing, He Shasha, Zhang Xiaokai, Zhang Guixiong, Li Jiaping

机构信息

Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China and Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.

Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.

出版信息

Front Oncol. 2022 Oct 26;12:1038279. doi: 10.3389/fonc.2022.1038279. eCollection 2022.

DOI:10.3389/fonc.2022.1038279

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9645243/

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.977348.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fonc.2022.977348。]

相似文献

1

Corrigendum: OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis regulating the arachidonic acid metabolism.勘误：OIT3通过介导铁死亡调节花生四烯酸代谢，作为肝细胞癌的一种新型生物标志物。

Front Oncol. 2022 Oct 26;12:1038279. doi: 10.3389/fonc.2022.1038279. eCollection 2022.

2

OIT3 serves as a novel biomarker of hepatocellular carcinoma by mediating ferroptosis regulating the arachidonic acid metabolism.OIT3通过介导铁死亡调节花生四烯酸代谢，作为肝细胞癌的一种新型生物标志物。

Front Oncol. 2022 Sep 5;12:977348. doi: 10.3389/fonc.2022.977348. eCollection 2022.

3

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma.勘误：肝细胞癌诊断和预后新型生物标志物的鉴定与验证。

Front Oncol. 2020 Nov 20;10:617539. doi: 10.3389/fonc.2020.617539. eCollection 2020.

4

Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma miR-145-SERPINE1 Axis.勘误：TARBP2缺失通过miR-145-SERPINE1轴驱动肝细胞癌进展。

Front Oncol. 2021 Sep 7;11:746958. doi: 10.3389/fonc.2021.746958. eCollection 2021.

5

Corrigendum: ASPM is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma.勘误：ASPM是一种预后生物标志物，与肾透明细胞癌和肝细胞癌中的免疫浸润相关。

Front Oncol. 2022 Aug 22;12:979968. doi: 10.3389/fonc.2022.979968. eCollection 2022.

6

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma.勘误：上调的LINC01667表达与肝细胞癌的不良预后相关。

Front Oncol. 2021 Oct 15;11:785394. doi: 10.3389/fonc.2021.785394. eCollection 2021.

7

Corrigendum: Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.勘误：单细胞转录组分析揭示恶性肝细胞亚群的代谢变化及预后价值并预测肝细胞癌的新治疗药物。

Front Oncol. 2023 Mar 8;13:1162375. doi: 10.3389/fonc.2023.1162375. eCollection 2023.

8

Corrigendum: Ribosomal protein L23 drives the metastasis of hepatocellular carcinoma upregulating MMP9.勘误：核糖体蛋白L23通过上调基质金属蛋白酶9驱动肝细胞癌转移。

Front Oncol. 2024 Mar 8;14:1373034. doi: 10.3389/fonc.2024.1373034. eCollection 2024.

9

Corrigendum: SPOCK1 promotes the development of hepatocellular carcinoma.勘误：SPOCK1促进肝细胞癌的发展。

Front Oncol. 2023 Apr 19;13:1203745. doi: 10.3389/fonc.2023.1203745. eCollection 2023.

10

Corrigendum: Pathogenetic, Prognostic, and Therapeutic Role of Fatty Acid Synthase in Human Hepatocellular Carcinoma.勘误：脂肪酸合酶在人类肝细胞癌中的发病机制、预后及治疗作用

Front Oncol. 2022 Apr 12;12:874053. doi: 10.3389/fonc.2022.874053. eCollection 2022.